The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hostager, B. S.
Right arrow Articles by Bishop, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hostager, B. S.
Right arrow Articles by Bishop, G. A.
The Journal of Immunology, 1999, 162: 6307-6311.
Copyright © 1999 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: Contrasting Roles of TNF Receptor-Associated Factor 2 (TRAF2) and TRAF3 in CD40-Activated B Lymphocyte Differentiation1

Bruce S. Hostager* and Gail A. Bishop2,*,{dagger},{ddagger}

Departments of * Microbiology and {dagger} Internal Medicine, University of Iowa, and {ddagger} VA Medical Center, Iowa City, IA 52242

In B lymphocytes, CD40 signals contribute to the activation of Ab secretion, isotype switching, T cell costimulation, and immunological memory. TRAF proteins appear to be important components of the CD40 signal transduction complex, but their roles in the activation of B cell effector functions are poorly understood. We examined the contributions of TNF receptor-associated factor 2 (TRAF2) and TRAF3 to CD40-activated differentiation in mouse B cells transfected with inducible TRAF and dominant-negative TRAF cDNAs. We find that binding of TRAF2 and TRAF3 to CD40 is not required for the induction of Ab secretion, but that both TRAF molecules can regulate the activation process. We demonstrate a negative regulatory role for TRAF3 and that this activity is dependent on the availability of an intact TRAF3-binding site in the cytoplasmic domain of CD40. In contrast, TRAF2 appears to play a positive role in B cell differentiation, and this activity is apparent even when its binding site on CD40 is disrupted.




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. P. Graham, C. R. Moore, and G. A. Bishop
Roles of the TRAF2/3 Binding Site in Differential B Cell Signaling by CD40 and Its Viral Oncogenic Mimic, LMP1
J. Immunol., September 1, 2009; 183(5): 2966 - 2973.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
H. H. Jabara, Y. Weng, T. Sannikova, and R. S. Geha
TRAF2 and TRAF3 independently mediate Ig class switching driven by CD40
Int. Immunol., April 1, 2009; 21(4): 477 - 488.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. L. Rowland, M. M. Tremblay, J. M. Ellison, L. L. Stunz, G. A. Bishop, and B. S. Hostager
A Novel Mechanism for TNFR-Associated Factor 6-Dependent CD40 Signaling
J. Immunol., October 1, 2007; 179(7): 4645 - 4653.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. H. Vonderheide
Prospect of Targeting the CD40 Pathway for Cancer Therapy
Clin. Cancer Res., February 15, 2007; 13(4): 1083 - 1088.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Xie, B. S. Hostager, M. E. Munroe, C. R. Moore, and G. A. Bishop
Cooperation between TNF Receptor-Associated Factors 1 and 2 in CD40 Signaling
J. Immunol., May 1, 2006; 176(9): 5388 - 5400.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. M. Andrade, M. Wessendarp, J.-A. C. Portillo, J.-Q. Yang, F. J. Gomez, J. E. Durbin, G. A. Bishop, and C. S. Subauste
TNF Receptor-Associated Factor 6-Dependent CD40 Signaling Primes Macrophages to Acquire Antimicrobial Activity in Response to TNF-{alpha}
J. Immunol., November 1, 2005; 175(9): 6014 - 6021.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Wu, P. Xie, K. Welsh, C. Li, C.-Z. Ni, X. Zhu, J. C. Reed, A. C. Satterthwait, G. A. Bishop, and K. R. Ely
LMP1 Protein from the Epstein-Barr Virus Is a Structural CD40 Decoy in B Lymphocytes for Binding to TRAF3
J. Biol. Chem., September 30, 2005; 280(39): 33620 - 33626.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. R. Moore and G. A. Bishop
Differential Regulation of CD40-Mediated TNF Receptor-Associated Factor Degradation in B Lymphocytes
J. Immunol., September 15, 2005; 175(6): 3780 - 3789.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Hauer, S. Puschner, P. Ramakrishnan, U. Simon, M. Bongers, C. Federle, and H. Engelmann
TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-{kappa}B pathway by TRAF-binding TNFRs
PNAS, February 22, 2005; 102(8): 2874 - 2879.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. E. Munroe and G. A. Bishop
Role of Tumor Necrosis Factor (TNF) Receptor-associated Factor 2 (TRAF2) in Distinct and Overlapping CD40 and TNF Receptor 2/CD120b-mediated B Lymphocyte Activation
J. Biol. Chem., December 17, 2004; 279(51): 53222 - 53231.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
P. Xie, B. S. Hostager, and G. A. Bishop
Requirement for TRAF3 in Signaling by LMP1 But Not CD40 in B Lymphocytes
J. Exp. Med., March 1, 2004; 199(5): 661 - 671.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. A. Haxhinasto and G. A. Bishop
Synergistic B Cell Activation by CD40 and the B Cell Antigen Receptor: ROLE OF B LYMPHOCYTE ANTIGEN RECEPTOR-MEDIATED KINASE ACTIVATION AND TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED FACTOR REGULATION
J. Biol. Chem., January 23, 2004; 279(4): 2575 - 2582.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Clatza, L. C. Bonifaz, D. A. A. Vignali, and J. Moreno
CD40-Induced Aggregation of MHC Class II and CD80 on the Cell Surface Leads to an Early Enhancement in Antigen Presentation
J. Immunol., December 15, 2003; 171(12): 6478 - 6487.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. S. Hostager, S. A. Haxhinasto, S. L. Rowland, and G. A. Bishop
Tumor Necrosis Factor Receptor-associated Factor 2 (TRAF2)-deficient B Lymphocytes Reveal Novel Roles for TRAF2 in CD40 Signaling
J. Biol. Chem., November 14, 2003; 278(46): 45382 - 45390.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L.-F. Lu, W. J. Cook, L.-L. Lin, and R. J. Noelle
CD40 Signaling through a Newly Identified Tumor Necrosis Factor Receptor-associated Factor 2 (TRAF2) Binding Site
J. Biol. Chem., November 14, 2003; 278(46): 45414 - 45418.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. A. Haxhinasto and G. A. Bishop
A Novel Interaction between Protein Kinase D and TNF Receptor-Associated Factor Molecules Regulates B Cell Receptor-CD40 Synergy
J. Immunol., November 1, 2003; 171(9): 4655 - 4662.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
Z. SM. Rahman, S. P. Rao, S. L. Kalled, and T. Manser
Normal Induction but Attenuated Progression of Germinal Center Responses in BAFF and BAFF-R Signaling-Deficient Mice
J. Exp. Med., October 20, 2003; 198(8): 1157 - 1169.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
C M Gelbmann, S N Leeb, D Vogl, M Maendel, H Herfarth, J Scholmerich, W Falk, and G Rogler
Inducible CD40 expression mediates NF{kappa}B activation and cytokine secretion in human colonic fibroblasts
Gut, October 1, 2003; 52(10): 1448 - 1456.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Propst, K. Estell, and L. M. Schwiebert
CD40-mediated Activation of NF-kappa B in Airway Epithelial Cells
J. Biol. Chem., September 27, 2002; 277(40): 37054 - 37063.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. A. Haxhinasto, B. S. Hostager, and G. A. Bishop
Cutting Edge: Molecular Mechanisms of Synergy Between CD40 and the B Cell Antigen Receptor: Role for TNF Receptor-Associated Factor 2 in Receptor Interaction
J. Immunol., August 1, 2002; 169(3): 1145 - 1149.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Qian, Z. Zhao, Z. Jiang, and X. Li
Role of NFkappa B activator Act1 in CD40-mediated signaling in epithelial cells
PNAS, July 9, 2002; 99(14): 9386 - 9391.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
G. A. Bishop, B. S. Hostager, and K. D. Brown
Mechanisms of TNF receptor-associated factor (TRAF) regulation in B lymphocytes
J. Leukoc. Biol., July 1, 2002; 72(1): 19 - 23.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. D. Brown, B. S. Hostager, and G. A. Bishop
Regulation of TRAF2 Signaling by Self-induced Degradation
J. Biol. Chem., May 24, 2002; 277(22): 19433 - 19438.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. S. Hostager and G. A. Bishop
Role of TNF Receptor-Associated Factor 2 in the Activation of IgM Secretion by CD40 and CD120b
J. Immunol., April 1, 2002; 168(7): 3318 - 3322.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. K. Busch and G. A. Bishop
Multiple Carboxyl-Terminal Regions of the EBV Oncoprotein, Latent Membrane Protein 1, Cooperatively Regulate Signaling to B Lymphocytes Via TNF Receptor-Associated Factor (TRAF)-Dependent and TRAF-Independent Mechanisms
J. Immunol., November 15, 2001; 167(10): 5805 - 5813.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
K. D. Brown, B. S. Hostager, and G. A. Bishop
Differential Signaling and Tumor Necrosis Factor Receptor-Associated Factor (Traf) Degradation Mediated by Cd40 and the Epstein-Barr Virus Oncoprotein Latent Membrane Protein 1 (Lmp1)
J. Exp. Med., April 16, 2001; 193(8): 943 - 954.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
Z. H. Lee, S. E. Lee, K. Kwack, W. Yeo, T. H. Lee, S. S. Bae, P.-G. Suh, and H.-H. Kim
Caspase-mediated cleavage of TRAF3 in FasL-stimulated Jurkat-T cells
J. Leukoc. Biol., March 1, 2001; 69(3): 490 - 496.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
G. A. Bishop, Y. Hsing, B. S. Hostager, S. V. Jalukar, L. M. Ramirez, and M. A. Tomai
Molecular Mechanisms of B Lymphocyte Activation by the Immune Response Modifier R-848
J. Immunol., November 15, 2000; 165(10): 5552 - 5557.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C.-Z. Ni, K. Welsh, E. Leo, C.-k. Chiou, H. Wu, J. C. Reed, and K. R. Ely
Molecular basis for CD40 signaling mediated by TRAF3
PNAS, September 12, 2000; 97(19): 10395 - 10399.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Cerutti, A. Schaffer, R. G. Goodwin, S. Shah, H. Zan, S. Ely, and P. Casali
Engagement of CD153 (CD30 Ligand) by CD30+ T Cells Inhibits Class Switch DNA Recombination and Antibody Production in Human IgD+ IgM+ B Cells
J. Immunol., July 15, 2000; 165(2): 786 - 794.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Bhushan, B. Barnhart, S. Shone, C. Song, and L. R. Covey
A Transcriptional Defect Underlies B Lymphocyte Dysfunction in a Patient Diagnosed with Non-X-Linked Hyper-IgM Syndrome
J. Immunol., March 15, 2000; 164(6): 2871 - 2880.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. V. Jalukar, B. S. Hostager, and G. A. Bishop
Characterization of the Roles of TNF Receptor-Associated Factor 6 in CD40-Mediated B Lymphocyte Effector Functions
J. Immunol., January 15, 2000; 164(2): 623 - 630.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.